Luoming Hua

SHIP1 is targeted by miR-155 in acute myeloid leukemia

Xue Hua, Luoming Hua, Ming Guo et al. · Oncology Reports · 2014 · 52 citations · Full text

Life Sciences, Molecular Biology, Oncology +10

Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center study

Jing Li, Li Bao, Zhongjun Xia et al. · Annals of Hematology · 2020 · 25 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Treatment and outcome patterns of patients with Waldenström’s macroglobulinemia: a large, multicenter retrospective review in China

Xinxin Cao, Shuhua Yi, Zhongxing Jiang et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2021 · 19 citations

Medicine, Hematology, Internal Medicine +13

Tumor‐associated macrophages regulate the function of cytotoxic T lymphocyte through <scp>PD</scp>‐1/<scp>PD‐L1</scp> pathway in multiple myeloma

Jiangbo Zhang, Zhaoyun Liu, Panpan Cao et al. · Cancer Medicine · 2022 · 17 citations · Full text

Medicine, Immunology, Oncology +15

Notable roles of EZH2 and DNMT1 in epigenetic dormancy of the SHP1 gene during the progression of chronic myeloid leukaemia

Jing Wang, Luoming Hua, Ming Guo et al. · Oncology Letters · 2017 · 14 citations · Full text

Life Sciences, Genetics, Molecular Biology +16